Milan
Italy
Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Department of Oncology
acquired resistance, platinum-based chemotherapy, CTLA-4 inhibitors, immunotherapy, non-small cell lung cancer
Immunotherapy, duration, survival, solid tumors